Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans - Ungerer, M; Rosport, K; Bültmann, A (Circulation, 2011)